Key points are not available for this paper at this time.
The fragile and limited production capacity of our 1950s egg-based technology for producing influenza vaccine and the lack of a national commitment to universal annual influenza vaccination mean that influenza epidemics will continue to present a substantial public health challenge. Dr. Michael Osterholm asks, So how can we prepare?
Michael T. Osterholm (Wed,) studied this question.